scholarly journals TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells

2013 ◽  
Vol 11 (2) ◽  
pp. 150-159 ◽  
Author(s):  
Hongliang Fang ◽  
Bing Ang ◽  
Xinyun Xu ◽  
Xiaohui Huang ◽  
Yanfeng Wu ◽  
...  
Keyword(s):  
T Cell ◽  
Dendritic Cell ◽  
Cancer Cells ◽  
Cell Response ◽  
Cell Activation ◽  
T Cell Response ◽  
Dendritic Cell Activation ◽  
Response Enhancement

scholarly journals Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation

2007 ◽  
Vol 104 (39) ◽  
pp. 15460-15465 ◽  
Author(s):  
R. Obst ◽  
H.-M. van Santen ◽  
R. Melamed ◽  
A. O. Kamphorst ◽  
C. Benoist ◽  
...  
Keyword(s):  
T Cell ◽  
Dendritic Cell ◽  
Antigen Presentation ◽  
Cell Response ◽  
Cell Activation ◽  
T Cell Response ◽  
Dendritic Cell Activation

scholarly journals The FcγRIIa–Syk Axis Controls Human Dendritic Cell Activation and T Cell Response Induced by Infliximab Aggregates

2020 ◽  
Vol 205 (9) ◽  
pp. 2351-2361 ◽  
Author(s):  
Myriam Nabhan ◽  
François-Xavier Legrand ◽  
Victor Le-Minh ◽  
Baptiste Robin ◽  
Rami Bechara ◽  
...  
Keyword(s):  
T Cell ◽  
Dendritic Cell ◽  
Cell Response ◽  
Cell Activation ◽  
T Cell Response ◽  
Human Dendritic Cell ◽  
Dendritic Cell Activation

scholarly journals IgG-Complexed Adenoviruses Induce Human Plasmacytoid Dendritic Cell Activation and Apoptosis

Viruses ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 1699
Author(s):  
Thi Thu Phuong Tran ◽  
Tuan Hiep Tran ◽  
Eric J. Kremer
Keyword(s):  
T Cell ◽  
Dendritic Cell ◽  
Cell Activation ◽  
Plasmacytoid Dendritic Cell ◽  
T Cell Response ◽  
Dendritic Cell Activation ◽  
Robust Immune Response ◽  
Persistent Infections ◽  
Repeat Exposure ◽  
Life Threatening

Following repeat exposure to many human adenoviruses (HAdVs), most adults harbour long-lived B- and T-cell responses. Combined, this response typically protects us for years from re-infection by the same HAdV type. In spite of these immune responses, some HAdV types are associated with persistent infections that constitute a life-threatening risk when an individual’s T-cell response is compromised. By contrast, patients with B-cell deficiencies do not appear to be at a greater risk of HAdV disease. This dichotomy begs the question of the secondary role of anti-HAdV antibodies during host defence. In this study, we explored IgG-complexed (IC)-HAdV5 and primary human plasmacytoid dendritic cell (pDC) interactions. We found that IC-HAdV5 are efficiently internalized in pDCs, stimulate their activation through TLR9 signalling, and cause apoptosis. These data may help reconcile the enigma of robust immune response to HAdVs, while concurrently allowing persistence.

scholarly journals Laser nanobubbles induce immunogenic cell death in breast cancer

Nanoscale ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 3644-3653
Author(s):  
Hieu T. M. Nguyen ◽  
Nitesh Katta ◽  
Jessica A. Widman ◽  
Eri Takematsu ◽  
Xu Feng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Death ◽  
Dendritic Cell ◽  
Cancer Cells ◽  
Breast Cancer Cells ◽  
Cell Activation ◽  
Immunogenic Cell Death ◽  
Dendritic Cell Activation

Laser nanobubbles induce dendritic cell activation in breast cancer cells.

scholarly journals Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity

Gut ◽  
2021 ◽  
pp. gutjnl-2020-322924
Author(s):  
Tuxiong Huang ◽  
Xiang-Yu Tan ◽  
Hui-Si Huang ◽  
Yu-Ting Li ◽  
Bei-Lei Liu ◽  
...  
Keyword(s):  
T Cell ◽  
Dendritic Cell ◽  
Cell Response ◽  
T Cell Responses ◽  
Tumour Microenvironment ◽  
T Cell Response ◽  
Cell Responses ◽  
Cancer Associated Fibroblast ◽  
Anticancer Immunotherapy ◽  
Novel Therapeutic Strategies

ObjectiveSolid tumours respond poorly to immune checkpoint inhibitor (ICI) therapies. One major therapeutic obstacle is the immunosuppressive tumour microenvironment (TME). Cancer-associated fibroblasts (CAFs) are a key component of the TME and negatively regulate antitumour T-cell response. Here, we aimed to uncover the mechanism underlying CAFs-mediated tumour immune evasion and to develop novel therapeutic strategies targeting CAFs for enhancing ICI efficacy in oesophageal squamous cell carcinoma (OSCC) and colorectal cancer (CRC).DesignAnti-WNT2 monoclonal antibody (mAb) was used to treat immunocompetent C57BL/6 mice bearing subcutaneously grafted mEC25 or CMT93 alone or combined with anti-programmed cell death protein 1 (PD-1), and the antitumour efficiency and immune response were assessed. CAFs-induced suppression of dendritic cell (DC)-differentiation and DC-mediated antitumour immunity were analysed by interfering with CAFs-derived WNT2, either by anti-WNT2 mAb or with short hairpin RNA-mediated knockdown. The molecular mechanism underlying CAFs-induced DC suppression was further explored by RNA-sequencing and western blot analyses.ResultsA negative correlation between WNT2+ CAFs and active CD8+ T cells was detected in primary OSCC tumours. Anti-WNT2 mAb significantly restored antitumour T-cell responses within tumours and enhanced the efficacy of anti-PD-1 by increasing active DC in both mouse OSCC and CRC syngeneic tumour models. Directly interfering with CAFs-derived WNT2 restored DC differentiation and DC-mediated antitumour T-cell responses. Mechanistic analyses further demonstrated that CAFs-secreted WNT2 suppresses the DC-mediated antitumour T-cell response via the SOCS3/p-JAK2/p-STAT3 signalling cascades.ConclusionsCAFs could suppress antitumour immunity through WNT2 secretion. Targeting WNT2 might enhance the ICI efficacy and represent a new anticancer immunotherapy.

Sign in / Sign up

Export Citation Format

Share Document